載入...
The elusive CML stem cell: does it matter and how do we eliminate it?
CML is a clonal multistep myeloproliferative disease originating from and ultimately sustained by a rare population of BCR-ABL(+) cells with multilineage stem cell properties. Imatinib, the most successful of molecular targeted therapies, has revolutionized treatment of patients with CML. Despite th...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948413/ https://ncbi.nlm.nih.gov/pubmed/20875553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2010.06.006 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|